Cargando…
MCM4 expression is associated with high-grade histology, tumor progression and poor prognosis in urothelial carcinoma
BACKGROUND: We previously reported Minichromosome maintenance 4 (MCM4) overexpression in gastric cancer. However, the clinicopathological significance of MCM4 in urothelial carcinoma (UC) has not been investigated. To clarify the clinicopathological significance of MCM4 in UC, we investigated MCM4 e...
Autores principales: | , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10515259/ https://www.ncbi.nlm.nih.gov/pubmed/37737200 http://dx.doi.org/10.1186/s13000-023-01392-y |
_version_ | 1785108909606830080 |
---|---|
author | Kobayashi, Go Hayashi, Tetsutaro Sentani, Kazuhiro Uraoka, Naohiro Fukui, Takafumi Kido, Aya Katsuya, Narutaka Ishikawa, Akira Babasaki, Takashi Sekino, Yohei Nose, Hiroyuki Arihiro, Koji Hinata, Nobuyuki Oue, Naohide |
author_facet | Kobayashi, Go Hayashi, Tetsutaro Sentani, Kazuhiro Uraoka, Naohiro Fukui, Takafumi Kido, Aya Katsuya, Narutaka Ishikawa, Akira Babasaki, Takashi Sekino, Yohei Nose, Hiroyuki Arihiro, Koji Hinata, Nobuyuki Oue, Naohide |
author_sort | Kobayashi, Go |
collection | PubMed |
description | BACKGROUND: We previously reported Minichromosome maintenance 4 (MCM4) overexpression in gastric cancer. However, the clinicopathological significance of MCM4 in urothelial carcinoma (UC) has not been investigated. To clarify the clinicopathological significance of MCM4 in UC, we investigated MCM4 expression with immunohistochemistry (IHC). METHODS: We analyzed the expression and distribution of MCM4 in 124 upper tract urothelial carcinoma (UTUC) samples by IHC. Additionally, using 108 urine samples, we analyzed MCM4 Immunocytochemistry (ICC) expression in urine cytology. RESULTS: In normal urothelium, MCM4 expression was weak or absent. Meanwhile, the strong nuclear expression of MCM4 was observed in UTUC tissues, and it was detected in 77 (62%) of a total of 124 UTUC cases. MCM4-positive UTUC cases were associated with nodular/flat morphology, high grade, high T stage, and poor prognosis. Moreover, MCM4 expression was significantly higher in the invasive front than in the tumor surface. Similar results were also obtained in TCGA bladder cancer cohort. Additionally, MCM4 expression was associated with high expression of Ki-67, HER2, EGFR, and p53 in UTUC. Among representative cancer-related molecules, MCM4 had an independent predictive value for progression-free survival and high-grade UC. ICC for MCM4 was also performed on urine cytology slides and showed that the nuclear expression of MCM4 was more frequently found in UC cells than in non-neoplastic cells. The diagnostic accuracy of urine cytology was improved by combining MCM4 immunostaining with cytology. CONCLUSION: These results suggest that MCM4 might be a useful predictive biomarker for high-grade histology, tumor progression and poor prognosis in UC. Moreover, ICC for MCM4 might be helpful for UC detection as additional markers in the cytomorphology-based diagnosis. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13000-023-01392-y. |
format | Online Article Text |
id | pubmed-10515259 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-105152592023-09-23 MCM4 expression is associated with high-grade histology, tumor progression and poor prognosis in urothelial carcinoma Kobayashi, Go Hayashi, Tetsutaro Sentani, Kazuhiro Uraoka, Naohiro Fukui, Takafumi Kido, Aya Katsuya, Narutaka Ishikawa, Akira Babasaki, Takashi Sekino, Yohei Nose, Hiroyuki Arihiro, Koji Hinata, Nobuyuki Oue, Naohide Diagn Pathol Research BACKGROUND: We previously reported Minichromosome maintenance 4 (MCM4) overexpression in gastric cancer. However, the clinicopathological significance of MCM4 in urothelial carcinoma (UC) has not been investigated. To clarify the clinicopathological significance of MCM4 in UC, we investigated MCM4 expression with immunohistochemistry (IHC). METHODS: We analyzed the expression and distribution of MCM4 in 124 upper tract urothelial carcinoma (UTUC) samples by IHC. Additionally, using 108 urine samples, we analyzed MCM4 Immunocytochemistry (ICC) expression in urine cytology. RESULTS: In normal urothelium, MCM4 expression was weak or absent. Meanwhile, the strong nuclear expression of MCM4 was observed in UTUC tissues, and it was detected in 77 (62%) of a total of 124 UTUC cases. MCM4-positive UTUC cases were associated with nodular/flat morphology, high grade, high T stage, and poor prognosis. Moreover, MCM4 expression was significantly higher in the invasive front than in the tumor surface. Similar results were also obtained in TCGA bladder cancer cohort. Additionally, MCM4 expression was associated with high expression of Ki-67, HER2, EGFR, and p53 in UTUC. Among representative cancer-related molecules, MCM4 had an independent predictive value for progression-free survival and high-grade UC. ICC for MCM4 was also performed on urine cytology slides and showed that the nuclear expression of MCM4 was more frequently found in UC cells than in non-neoplastic cells. The diagnostic accuracy of urine cytology was improved by combining MCM4 immunostaining with cytology. CONCLUSION: These results suggest that MCM4 might be a useful predictive biomarker for high-grade histology, tumor progression and poor prognosis in UC. Moreover, ICC for MCM4 might be helpful for UC detection as additional markers in the cytomorphology-based diagnosis. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13000-023-01392-y. BioMed Central 2023-09-22 /pmc/articles/PMC10515259/ /pubmed/37737200 http://dx.doi.org/10.1186/s13000-023-01392-y Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Kobayashi, Go Hayashi, Tetsutaro Sentani, Kazuhiro Uraoka, Naohiro Fukui, Takafumi Kido, Aya Katsuya, Narutaka Ishikawa, Akira Babasaki, Takashi Sekino, Yohei Nose, Hiroyuki Arihiro, Koji Hinata, Nobuyuki Oue, Naohide MCM4 expression is associated with high-grade histology, tumor progression and poor prognosis in urothelial carcinoma |
title | MCM4 expression is associated with high-grade histology, tumor progression and poor prognosis in urothelial carcinoma |
title_full | MCM4 expression is associated with high-grade histology, tumor progression and poor prognosis in urothelial carcinoma |
title_fullStr | MCM4 expression is associated with high-grade histology, tumor progression and poor prognosis in urothelial carcinoma |
title_full_unstemmed | MCM4 expression is associated with high-grade histology, tumor progression and poor prognosis in urothelial carcinoma |
title_short | MCM4 expression is associated with high-grade histology, tumor progression and poor prognosis in urothelial carcinoma |
title_sort | mcm4 expression is associated with high-grade histology, tumor progression and poor prognosis in urothelial carcinoma |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10515259/ https://www.ncbi.nlm.nih.gov/pubmed/37737200 http://dx.doi.org/10.1186/s13000-023-01392-y |
work_keys_str_mv | AT kobayashigo mcm4expressionisassociatedwithhighgradehistologytumorprogressionandpoorprognosisinurothelialcarcinoma AT hayashitetsutaro mcm4expressionisassociatedwithhighgradehistologytumorprogressionandpoorprognosisinurothelialcarcinoma AT sentanikazuhiro mcm4expressionisassociatedwithhighgradehistologytumorprogressionandpoorprognosisinurothelialcarcinoma AT uraokanaohiro mcm4expressionisassociatedwithhighgradehistologytumorprogressionandpoorprognosisinurothelialcarcinoma AT fukuitakafumi mcm4expressionisassociatedwithhighgradehistologytumorprogressionandpoorprognosisinurothelialcarcinoma AT kidoaya mcm4expressionisassociatedwithhighgradehistologytumorprogressionandpoorprognosisinurothelialcarcinoma AT katsuyanarutaka mcm4expressionisassociatedwithhighgradehistologytumorprogressionandpoorprognosisinurothelialcarcinoma AT ishikawaakira mcm4expressionisassociatedwithhighgradehistologytumorprogressionandpoorprognosisinurothelialcarcinoma AT babasakitakashi mcm4expressionisassociatedwithhighgradehistologytumorprogressionandpoorprognosisinurothelialcarcinoma AT sekinoyohei mcm4expressionisassociatedwithhighgradehistologytumorprogressionandpoorprognosisinurothelialcarcinoma AT nosehiroyuki mcm4expressionisassociatedwithhighgradehistologytumorprogressionandpoorprognosisinurothelialcarcinoma AT arihirokoji mcm4expressionisassociatedwithhighgradehistologytumorprogressionandpoorprognosisinurothelialcarcinoma AT hinatanobuyuki mcm4expressionisassociatedwithhighgradehistologytumorprogressionandpoorprognosisinurothelialcarcinoma AT ouenaohide mcm4expressionisassociatedwithhighgradehistologytumorprogressionandpoorprognosisinurothelialcarcinoma |